Author = Maryam Rameshrad
Ashwagandha (Withania somnifera) in insulin resistance and metabolic syndrome: A literature review on mechanisms

Volume 29, Issue 1, January 2026, Pages 3-21

10.22038/ijbms.2025.86747.18741

Emad Azimi; Maryam Rameshrad; Mahboobeh Ghasemzadeh Rahbardar; Hossein Hosseinzadeh


Syringic acid, a promising natural compound for the prevention and management of metabolic syndrome: A systematic review

Volume 28, Issue 11, November 2025, Pages 1456-1476

10.22038/ijbms.2025.85940.18568

Habibeh Mashayekhi-Sardoo; Fatemeh Sadeghzadeh; Maryam Rameshrad; Hossein Hosseinzadeh


Carnosic acid mitigates doxorubicin-induced cardiac toxicity: Evidence from animal and cell model investigations

Volume 27, Issue 4, April 2024, Pages 425-438

10.22038/ijbms.2023.71508.15544

Mahboobeh Ghasemzadeh Rahbardar; Farhad Eisvand; Maryam Rameshrad; Bibi Marjan Razavi; Abbass Tabatabaee Yazdi; Hossein Hosseinzadeh


An overview of glucagon-like peptide-1 receptor agonists for the treatment of metabolic syndrome: A drug repositioning

Volume 23, Issue 5, May 2020, Pages 556-568

10.22038/ijbms.2020.41638.9832

Maryam Rameshrad; Bibi Marjan Razavi; Jean-Daniel Lalau; Marc E. De Broe; Hossein Hosseinzadeh


Evaluation of possible effects of crocin against nitrate tolerance and endothelial dysfunction

Volume 23, Issue 3, March 2020, Pages 303-310

10.22038/ijbms.2019.39604.9389

Seyedeh Farzaneh Omidkhoda; Marjan Razavi; Mohsen Imenshahidi; Maryam Rameshrad; Hossein Hosseinzadeh